Skip to Main Content
Pharmacy Technician's Letter Canada
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • Natural Medicines Resources
  • CE & Training
    • CE Organizer
    • Available Courses
    • Live CE Calendar
    • Print Statements
    • Licenses
    • Additional Requirements
    • Exemptions
  • New Drugs
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Interactions
  4. Gastroenterology
  5. Antacids

Antacids

  • Bone & Joint (49)
  • Cardiology (187)
  • Dermatology (47)
  • Diabetes & Endocrinology (40)
  • Gastroenterology (57)
    • Antacids (18)
    • Cisapride (7)
    • H2 Receptor Antagonists (6)
    • Other (15)
    • PPIs (27)
  • Hematology & Oncology (6)
  • Infectious Diseases (179)
  • Men's Health (3)
  • Natural Medicines / Supplements / Food Interactions (120)
  • Neurology (106)
  • Nutrition & Obesity (8)
  • Psychiatry (109)
  • Resources (33)
  • Respiratory & Allergy (14)
  • Transplant Meds (13)
  • Women's Health (43)
1 - 15 of 18 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Chart: Antibiotics for MRSA Skin Infections December 2021
Chart: OTC Brand-Name Extensions July 2021
Article: Watch for Patients Taking Iron Every OTHER Day September 2020
Chart: Comparison of Oral Anticoagulants December 2019
Chart: New Formulation: Dovato (Dolutegravir-Lamivudine) November 2019
Article: Be Prepared to Dispense Dovato, a New Combo Med for HIV November 2019
Article: Look Out for Risky Drug Interactions With Hepatitis C Meds July 2019
Chart: Hepatitis C Treatment Overview July 2019
Commentary: Symtuza Approved in Canada June 2018
Guideline: Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV, 2018 June 2018
Article: Symtuza and Biktarvy Will Join Other Combos for Treating HIV June 2018
Checklist: HIV Patient Transitions of Care Checklist May 2017
Other: Hepatitis C: What Pharmacy Technicians Need to Know September 2016
Article: Encourage Epclusa Patients to Refill Their Hepatitis C Med Several Days Early September 2016
Article: Double-Check Product Labels to See if An Antacid Contains Aspirin August 2016
  • 1
  • 2
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved